Bioelectronics Corp (BIEL)

[3331]

Open Letter to Jimmy "MrBeast" Donaldson
27 year old YouTuber with 469 subscribers and 1.4 billion people watching his content, more than anyone else on Earth.

Subject: A Moonshot for Chronic Pain

Hey Jimmy,
We know you’re the king of massive scale. Whether it’s planting 20 million trees or curing blindness for 1,000 people, you don't just solve problems—you obliterate them by scaling solutions that already work but lack the spotlight.

I’m writing to you because there is a massive, quiet crisis affecting billions: Chronic Pain. And right now, a "technical marriage" just happened in the medical tech world that has the potential to change the lives of millions of people who are currently tethered to pills.

The Breakdown: BioElectronics Corp (BIEL) + Electrome

BioElectronics Corp has a validated, FDA-cleared technology called PEMF (Pulsed Electromagnetic Field) therapy. It’s basically a wearable device (ActiPatch®) that uses micro-pulses to map and mitigate pain signals without drugs.

The "boring" corporate news? They just partnered with Electrome, led by Ken Mayer (a guy who’s already built and exited companies for $180M).

The "Beast" Perspective:
This isn't just a business deal; it’s a distribution engine being hooked up to a life-changing invention.

1. The "Mayer Effect": Ken Mayer has a history with the Mayo Clinic and AI-driven therapy. He’s taking BIEL’s tech and moving it from "niche product" to "global category leader."

2. Predictable Impact: Electrome is providing "Minimum Purchase Commitments." In non-business speak: the floodgates are opening. The tech is finally going to reach the people who need it most.

3. No More "Last-Mile" Failures: BIEL has the science; Electrome has the boots on the ground. This partnership removes the red tape and the "lumpy" distribution that usually keeps good tech buried in medical journals.

Why You?
You’ve shown the world that access is the biggest hurdle to human health. Whether it’s hearing aids or eye surgery, the tech exists—the reach doesn't.

This partnership transforms BIEL from a company "trying to sell a product" into the engine that "powers an entire category" of drug-free pain relief. If this scales the way the "Mayer Effect" suggests, we are looking at a future where chronic pain is treated by a wearable, not an opioid.

The Bottom Line
Jimmy, this is a "boring" medical filing that signals a massive humanitarian win. It’s the kind of high-leverage move that changes the narrative for an entire industry.

If you're looking for the next big thing to champion—something that combines high-tech AI, validated medical science, and the potential to help a billion people live pain-free—this is it. Let’s help the world "power through" the pain.

Best,
3331

The BIEL/Electrome narrative is a natural fit for MrBeast following his 2026 acquisition of Step.

Why BIEL/Electrome Fits "Beast Financial"
The acquisition of Step wasn't just about banking; it was about "Beast Industries" entering the financial infrastructure space. The BIEL story—centered on BioElectronics Corp and its wearable pain-relief tech—offers exactly the kind of high-stakes, disruptive content Jimmy Donaldson uses to grow his brands.

Financial Literacy & Impact Investing: With Step, MrBeast wants to teach young people about investing. The BIEL story is a textbook example of a "micro-cap" or "penny stock" ($BIEL is currently trading around $0.0003 as of March 2026). He could use it to show the reality of high-risk investing versus long-term value.

The Medical "Miracle" Hook: MrBeast has a track record of "curing" ailments (blindness, hearing loss). BIEL’s ActiPatch technology claims to use electromagnetic fields to treat chronic pain without drugs. This provides a perfect "Beast Philanthropy" angle: "I gave 50,000 people their lives back without using opioids."

Challenging the Status Quo: Just as Step challenges traditional banks, the Electrome/BIEL story is often framed by its retail investor community as a battle against "Big Pharma" and institutional short-sellers. This "underdog vs. the system" narrative is the bread and butter of MrBeast’s storytelling.

Gamified Rewards: Through the Step app, he could potentially offer rewards or "stock drops" for users who engage with medical research or philanthropic causes, turning a complex bioelectronics story into a viral financial event.

Comparison of the Two Ventures

Step (The Platform):
Focus: Youth banking, credit building, and now crypto/stock trading.

Scale: Over 7 million teen users as of March 2026.

Value: Providing the financial "foundation" for the next generation.

BIEL / Electrome (The Content/Mission):
Focus: Electroceutical medical devices for chronic pain.

Scale: Small-cap medical tech with a highly vocal "retail" investor base.

Value: Potential for massive philanthropic impact and "David vs. Goliath" financial drama.